A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDSUlrich Keilholz, Carmen Scheibenbogen, Igor Wolfgang Blau et al.|Blood|2009Cited by 300